Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature
Esther M. van der Zwaal, Myrte Merkestein, Yan-yee Lam, et al.
International Journal of Obesity (2011) Vol. 36, Iss. 2, pp. 254-261
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Molecular pathophysiology of metabolic effects of antipsychotic medications
Jacob S. Ballon, Utpal B. Pajvani, Zachary Freyberg, et al.
Trends in Endocrinology and Metabolism (2014) Vol. 25, Iss. 11, pp. 593-600
Closed Access | Times Cited: 109
The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain
Meng Xiao He, Chao Deng, Xu‐Feng Huang
CNS Drugs (2013) Vol. 27, Iss. 6, pp. 423-434
Closed Access | Times Cited: 104
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 76
Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives
Raghunath Singh, Yashika Bansal, Bikash Medhi, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 231-240
Closed Access | Times Cited: 68
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
Zachary Freyberg, Despoina Aslanoglou, Ripal Shah, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 66
Gut Microbiota and Time-Restricted Feeding/Eating: A Targeted Biomarker and Approach in Precision Nutrition
Falak Zeb, Tareq M. Osaili, Reyad S. Obaid, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 259-259
Open Access | Times Cited: 20
Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats
Qingsheng Zhang, Jiamei Lian, Meng Xiao He, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 51, pp. 172-180
Closed Access | Times Cited: 59
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 44
Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update
Ann Verhaegen, Luc F. Van Gaal
Current Obesity Reports (2021) Vol. 10, Iss. 1, pp. 1-13
Closed Access | Times Cited: 32
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
The role of ghrelin signalling in second-generation antipsychotic-induced weight gain
Qingsheng Zhang, Chao Deng, Xu‐Feng Huang
Psychoneuroendocrinology (2013) Vol. 38, Iss. 11, pp. 2423-2438
Closed Access | Times Cited: 54
Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia
Cuirong Zeng, Ping Yang, Ting Cao, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110097-110097
Closed Access | Times Cited: 32
Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
Shen-Chieh Chang, Kah Kheng Goh, Mong‐Liang Lu
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 696-710
Open Access | Times Cited: 29
Modelling olanzapine-induced weight gain in rats
Esther M. van der Zwaal, Sanna K. Janhunen, Susanne E. la Fleur, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 169-186
Closed Access | Times Cited: 40
Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
Kateřina Horská, Jana Kučerová, Zuzana Babinská, et al.
Psychoneuroendocrinology (2016) Vol. 73, pp. 177-185
Closed Access | Times Cited: 32
Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight
Vítor Ferreira, Cintia Folgueira, María Guillén, et al.
Metabolism (2022) Vol. 137, pp. 155335-155335
Open Access | Times Cited: 13
Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels
Raghunath Singh, Yashika Bansal, Rupinder Kaur Sodhi, et al.
Life Sciences (2020) Vol. 247, pp. 117442-117442
Closed Access | Times Cited: 20
Olanzapine-Activated AMPK Signaling in the Dorsal Vagal Complex Is Attenuated by Histamine H1 Receptor Agonist in Female Rats
Meng Xiao He, Qingsheng Zhang, Chao Deng, et al.
Endocrinology (2014) Vol. 155, Iss. 12, pp. 4895-4904
Open Access | Times Cited: 20
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation
Kateřina Horská, Hana Kotolová, Michal Karpíšek, et al.
Toxicology and Applied Pharmacology (2020) Vol. 406, pp. 115214-115214
Closed Access | Times Cited: 15
Olanzapine-Induced Activation of Hypothalamic Astrocytes and Toll-Like Receptor-4 Signaling via Endoplasmic Reticulum Stress Were Related to Olanzapine-Induced Weight Gain
Meng Xiao He, Kun Qian, Ying Zhang, et al.
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 11
Phosphorylation of hypothalamic AMPK on serine485/491 related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine
Hyunjeong Kim, Minsun Park, SuKyoung Lee, et al.
Psychopharmacology (2014) Vol. 231, Iss. 20, pp. 4059-4069
Closed Access | Times Cited: 11
Genetic Variation in the GCG and in the GLP1R Genes and Antipsychotic-Induced Weight Gain
Eva J. Brandl, Arun K. Tiwari, Nabilah I. Chowdhury, et al.
Pharmacogenomics (2014) Vol. 15, Iss. 4, pp. 423-431
Closed Access | Times Cited: 11
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet
Foteini Delis, Lauren Rosko, Aditya Shroff, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 79, pp. 268-280
Closed Access | Times Cited: 11
Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs
Peter Manu, Christoph U. Correll, Martien Wampers, et al.
European Neuropsychopharmacology (2012) Vol. 23, Iss. 3, pp. 205-211
Closed Access | Times Cited: 10
Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression
Simon S. Evers, Gretha J. Boersma, Kellie L. Tamashiro, et al.
Journal of Psychopharmacology (2017) Vol. 31, Iss. 11, pp. 1437-1452
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top